Syncom Formulations (India) Ltd share price logo

Syncom Formulations (India) Ltd (SYNCOMF)

₹12.90.77%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Syncom Formulations (India) Ltd share Performance

  • ₹12.85
    ₹13.25
    ₹12.9
    downward going graph

    0.39%

    Low

    Day's Volatility:3.10%

    High

    2.71%

    downward going graph
  • ₹6.25
    ₹18.65
    ₹12.9
    downward going graph

    51.55%

    Low

    52 Weeks Volatility:96.12%

    High

    44.57%

    downward going graph
1 Month Return-7.47 %
3 Month Return-13.04 %
1 Year Return+ 103.12 %
Previous Close₹13.00
Open₹13.00
Volume25.77L
Upper Circuit-
Lower Circuit-
Market Cap₹1,222.00Cr

Company Information

Syncom Formulations India is a public limited company that was established in 1988 and converted to public limited in 1992. It manufactures pharmaceutical formulations, injectibles, ear/eye drops, and herbal products such as Edicare Attom Megacaps Ecziguard and Yas antacid salt. The company started its expansion project in 1994 of setting up a new manufacturing plant in Pithampur Madhya Pradesh which was completed in 1995. During the financial year 1998-99, big expansions in the installed capacity and production base, and the introduction of products in the generic OTC and Ethical divisions were made. The exports boasted an increase of more than 100% and received orders worth Rs.700 lacs. It has been approved as a supplier to Central ESI Hospitals and registered for defence services that will augment the sales volume. Syncom Formulations India is continuously working towards growth and aims to significantly increase its product portfolio and customer base.

Share Price: ₹12.90 per share as on 24 May, 2024 04:01 PM
Market Capitalisation: ₹1,222.00Cr as of today
Revenue: ₹74.57Cr as on March 2024 (Q1 24)
Net Profit: ₹7.40Cr as on March 2024 (Q1 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
OrganisationSyncom Formulations (India) Ltd
HeadquartersIndore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Syncom Formulations (India) Ltd

  • Syncom Formula Reports 19.39% YoY Growth in Net Sales - 20 May, 2024

    Syncom Formulations (India) Ltd reports a 19.39% YoY growth in net sales for March 2024, with quarterly net profit at Rs. 6.75 crore, down 20.29% from the previous year. The company's EPS has also decreased to Rs. 0.09 in March 2024. Syncom Formula shares closed at 13.40 on May 17, 2024 (NSE), providing 36.04% returns over the last 6 months and 109.38% over the last 12 months.

Fundamentals of Syncom Formulations (India) Ltd

Insights on Syncom Formulations (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 4.4 Cr → 7.4 Cr (in ₹), with an average increase of 14.9% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.08% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 61.71 Cr → 77.67 Cr (in ₹), with an average increase of 7.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.57% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 115.5% return, outperforming this stock by 12.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 116.4% return, outperforming this stock by 31.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SYNCOMF stock has moved down by -3.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.43% to 49.35% in Mar 2024 quarter

Syncom Formulations (India) Ltd Valuation

Syncom Formulations (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.98x)

March 12, 2020

Today (38.24x)

May 23, 2024

Industry (63.13x)

May 23, 2024

Highest (81.74x)

January 18, 2022

LowHigh

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
50.57%
0.00
Foreign Institutions
0.08%
0.00
Mutual Funds
0%
0.00
Retail Investors
49.35%
0.00
Others
0%
0.00

Technicals of Syncom Formulations (India) Ltd share

News & Events of Syncom Formulations (India) Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Syncom Formulations (India) Ltd shares.

Syncom Formulations (India) Ltd (SYNCOMF) share price today is ₹12.9

Syncom Formulations (India) Ltd is listed on NSE

Syncom Formulations (India) Ltd is listed on BSE

  • Today’s highest price of Syncom Formulations (India) Ltd is ₹13.25.
  • Today’s lowest price of Syncom Formulations (India) Ltd is ₹12.85.

PE Ratio of Syncom Formulations (India) Ltd is 38.24

PE ratio = Syncom Formulations (India) Ltd Market price per share / Syncom Formulations (India) Ltd Earnings per share

Today’s traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 25.77L.

Today’s market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1222Cr.

Syncom Formulations (India) Ltd(SYNCOMFPrice
52 Week High
₹18.65
52 Week Low
₹6.25

Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹12.9. It is down -30.83% from its 52 Week High price of ₹18.65

Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹12.9. It is up 106.40% from its 52 Week Low price of ₹6.25

Syncom Formulations (India) Ltd(SYNCOMFReturns
1 Day Returns
-0.1%
1 Month Returns
-7.47%
3 Month Returns
-13.04%
1 Year Returns
103.12%